About this trial
In preterm infants \< 34 weeks' gestation at birth receiving respiratory support with invasive positive pressure ventilation, the positive end-expiratory pressure (PEEP) of best compliance will increase the cardiac output and improve oxygenation. This study may emphasize using point-of-care echocardiography along with electrical impedance tomography (EIT) to optimize ventilator settings in preterm infants.
Infants will be randomized to a 4-hour crossover period of increasing and decreasing PEEP in random order from baseline to determine compliance, oxygenation, and cardiac hemodynamics at each step using echocardiography (ECHO) and EIT measurements. There will be a 15-minute washout period after changes prior to data collection.
Eligibility criteria
Qualifiers
Post-natal age > 7 days and less than 1 month (outside golden week protocol)
Gestational age ≥ 21 weeks and ≤ 34 week
Infants with written informed consent obtained from legal guardian
Disqualifiers
Blood culture-positive sepsis
Congenital anomalies affecting respiration
Cyanotic or ductal-dependent congenital heart disease
Newborns who are considered too unstable for study enrolment per neonatology attending
Trial design
Treatments tested in this trial
- Increase in the PEEP followed by decrease in the PEEP
- Decrease in the PEEP followed by increase in the PEEP